Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients

Abstract Neuroendocrine prostate cancer (NEPC), a highly aggressive variant of castration-resistant prostate cancer (CRPC), often emerges upon treatment with androgen pathway inhibitors, via neuroendocrine differentiation. Currently, NEPC diagnosis is challenging as available markers are not suffici...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Divya Bhagirath, Michael Liston, Theresa Akoto, Byron Lui, Barbara A. Bensing, Ashok Sharma, Sharanjot Saini
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d5214699fc2a4b7883f1e1dd59762ab6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!